Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study
Taishi Hata(The University of Osaka), Hidetoshi Eguchi(Osaka Gakuin University), Masayuki Ohue(Hyogo Medical University), Ho Min Kim(Korea Advanced Institute of Science and Technology), Tsunekazu Mizushima(The University of Osaka), Yuichiro� Doki(Osaka Gakuin University), Ken Konishi(Hyogo Prefectural Nishinomiya Hospital), Hideki Osawa(Hokkaido University), Anna Tsutsui(Osaka Health Science University), Yuko Ohno(Hyogo Prefectural Nishinomiya Hospital), Mitsuyoshi Tei(Osaka Rosai Hospital), Chu Matsuda(Osaka International Cancer Institute), Hiroyoshi Takemoto(Kinki Central Hospital), Kohei Murata(Suita Municipal Hospital), Kiyotaka Hagihara(Kishiwada City Hospital), Hiroki Akamatsu(Osaka Hospital), Tatsushi Shingai(Kinki Central Hospital), Masakazu Ikenaga(Osaka National Hospital), Mamoru Uemura(Osaka International Cancer Institute)
Cited by 8
Related Papers
Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
|Clinical Cancer Research|2011|245
Implications of Nectin-like Molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in Cell-Cell Adhesion and Transmembrane Protein Localization in Epithelial Cells
|Journal of Biological Chemistry|2003|231
Atomically accurate de novo design of antibodies with RFdiffusion
|bioRxiv (Cold Spring Harbor Laboratory)|2024|186